Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody

By Soda R.   Costanzo A.   Cantonetti M.   Orlandi A.   Bianchi L.   Chimenti S.  

Acta Dermato-Venereologica, Vol. 81, Iss. 3, 2001-06 ,pp. : 207-208

Medical Journals Limited

Access to resources Recommend Favorite

Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): Five cases

By Antonucci Angela   Negosanti Massimino   Tabanelli Michela   Varotti Claudio  

Journal of Dermatological Treatment, Vol. 18, Iss. 3, 2007-01 ,pp. : 178-183

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody Rituximab

By Schumann Tamara   Schmidt Enno   Booken Nina   Goerdt Sergij   Goebeler Matthias  

Acta Dermato-Venereologica, Vol. 89, Iss. 1, 2009-01 ,pp. : 101-102

Medical Journals Limited

Access to resources Recommend Favorite

In vitro Propagation and Dynamics of T cells from Skin Biopsies by Methods Using Interleukins-2 and -4 or Anti-CD3/CD28 Antibody-coated Microbeads

By Hashizume Hideo   Hansen Anker   Poulsen Lars K.   Thomsen Allan Randrup   Takigawa Masahiro   Thestrup-Pedersen Kristian  

Acta Dermato-Venereologica, Vol. 90, Iss. 5, 2010-09 ,pp. : 468-473

Medical Journals Limited

Access to resources Recommend Favorite

Low-dose Anti-thymocyte Globulin Inhibits Human B-cell Differentiation into Antibody-Secreting Cells

By Klaus Pascal   Heine Guido   Rasche Claudia   Worm Margitta  

Acta Dermato-Venereologica, Vol. 95, Iss. 6, 2015-06 ,pp. : 676-680

Medical Journals Limited

Access to resources Recommend Favorite